- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04807270
PRP Effectiveness in Knee Osteoarthritis (PRP)
March 17, 2021 updated by: Sinan GOK, Istanbul University
Efficacy of Two Different Platelet Rich Plasma Methods in Patients With Knee Osteoarthritis: A Randomized Controlled Study
The aim of our study is to determine the effects of intra-articular Platelet Rich Plasma (PRP) prepared with two different techniques on pain intensity, functional status, quality of life, functional balance and femoral cartilage thickness in patients with knee osteoarthritis.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Osteoarthritis (OA) is the most common form of chronic joint disease.
Platelet Rich Plasma (PRP) is an injection therapy used to treat chronic painful musculoskeletal conditions, including knee OA.
In this prospective, randomized controlled, single blind, interventional study, a total of 75 patients with stage 2-3 knee osteoarthritis according to the kellgren lawrence classification who meet the eligibility criteria will be enrolled in the study.
Eligible participants will be randomly assigned to one of the three groups using computer-generated random numbers.The patients to be included in the study will be randomized into three groups and the first group will be given platelet-rich plasma (PRP) prepared with T-LAB / PRP KIT, the second group will be given PRP prepared with T-LAB PRP INJECTION SYRINGA, and the third group will be given saline injection.
Home exercise program for knee osteoarthritis will be given to all three groups and the exercise program will be followed by weekly phone calls.
During the follow-up period, patients will be asked to continue their current medical treatments, not to make changes in their activities of daily living.
Participants are going to evaluate before injection, and at the 1-month follow-up and 6-month follow-up using the visual analog scale (VAS) scores for pain during activity, at rest, and at night, with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) change in pain, stiffness and physical function score, the change in the Timed Up and Go Test (TUG) time, change in femoral cartilage thickness measurement by ultrasound and the change in the patient's daily activities with the numerical global patient assessment scale.
Study Type
Interventional
Enrollment (Anticipated)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sinan Gok, MD
- Phone Number: 12856 +902124142000
- Email: sinan.gok@istanbul.edu.tr
Study Contact Backup
- Name: Yunus Emre Dogan, MD
- Phone Number: 12856 +902124142000
- Email: emredogan91@istanbul.edu.tr
Study Locations
-
-
Fatıh
-
Istanbul, Fatıh, Turkey, 34034
- Recruiting
- Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
-
Contact:
- Sinan Gok, MD
- Phone Number: 12856 +902124142000
- Email: sinan.gok@istanbul.edu.tr
-
Contact:
- Ekin I Sen, Asst. Prof.
- Phone Number: 12856 +902124142000
- Email: ekinozgorgu@gmail.com
-
Principal Investigator:
- Ekin I Sen, Asst. Prof
-
Sub-Investigator:
- Demirhan Diracoglu, Profesor
-
Sub-Investigator:
- Yunus Emre Dogan, MD
-
Sub-Investigator:
- Sinan Gok, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with chronic symptomatic knee pain between the ages of 30-75 years
- Presence of Kellgren-Lawrence stage 2-3 osteoarthritis on current anterior-posterior knee radiographs
- Functional ambulation scale stage 4-5
Exclusion Criteria:
- Intra-articular knee injection within the last six months
- History of severe trauma to the knee within the past six months
- Concomitant severe meniscus or ligament injury, surgery applied to the knee area
- Presence of severe effusion, inflammatory joint disease, infection, hematological and oncological disease in the knee.
- Having a bleeding disorder and / or using warfarin
- Kellgren-Lawrence stage 1 or stage 4 osteoarthritis on current anterior-posterior knee radiographs
- Presence of cardiac or systemic disease that may affect exercise
- The presence of neurological disease and psychiatric disease such as Parkinson's disease, stroke history that may affect balance
- Body Mass Index ≥35 kg / m²
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: T-LAB / PRP KIT
In the first group, Platelet-rich plasma (PRP) prepared with T-LAB / PRP KIT injection in 3 sessions will be applied.
|
Intra-articular 3 ml T-LAB / PRP KIT injection in 3 sessions will be applied.
As a home exercise program, hamstring and quadriceps stretching, quadriceps isometric strengthening, short arc terminal extension exercises will be given at least three days a week with 3 sets of 10 repetitions.
|
ACTIVE_COMPARATOR: T-LAB / PRP INJECTION SYRINGE
In the first group, Platelet-rich plasma (PRP) prepared with T-LAB / PRP INJECTION SYRINGE injection in 3 sessions will be applied.
|
Intra-articular 3 ml T-LAB / PRP INJECTION SYRINGE injection in 3 sessions will be applied.
As a home exercise program, hamstring and quadriceps stretching, quadriceps isometric strengthening, short arc terminal extension exercises will be given at least three days a week with 3 sets of 10 repetitions.
|
ACTIVE_COMPARATOR: SALINE
In the first group, Platelet-rich plasma (PRP) prepared with SALINE injection in 3 sessions will be applied.
|
Intra-articular 3 ml SALINE injection in 3 sessions will be applied.
As a home exercise program, hamstring and quadriceps stretching, quadriceps isometric strengthening, short arc terminal extension exercises will be given at least three days a week with 3 sets of 10 repetitions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline activity pain score at 1-months and 6-months
Time Frame: Baseline, 1-month, 6-month
|
Visual Analogue Scale-Activity pain (0-10 point).
Higher scores mean a worse outcome
|
Baseline, 1-month, 6-month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline rest pain score at 1-months and 6-months
Time Frame: Baseline, 1-month, 6-month
|
Visual Analogue Scale-Rest pain (0-10 point).
Higher scores mean a worse outcome
|
Baseline, 1-month, 6-month
|
Change from baseline night pain score at 1-months and 6-months
Time Frame: Baseline, 1-month, 6-month
|
Visual Analogue Scale-Night pain (0-10 point).
Higher scores mean a worse outcome
|
Baseline, 1-month, 6-month
|
Change from baseline pain, stiffness and physical function at 1-months and 6-months
Time Frame: Baseline, 1-month, 6-month
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) measures knee pain, stiffness, and physical function.
The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function.
The sum of the scores for the three subscales gives a total WOMAC score.
High scores are associated with more pain, stiffness, and poor function, while low scores indicate well-being.
|
Baseline, 1-month, 6-month
|
Change from baseline functional balance at 1-months and 6-months
Time Frame: Baseline, 1-month, 6-month
|
The Timed Up and Go test requires the person to stand up from a standard chair in which they are sitting, walk 3 m at a comfortable speed to the marked place on the floor, turn around, walk backwards to the starting point and return to the sitting position in the chair.
The time taken for the person to complete the test is measured in seconds.
The timing of the test is related to the function.
|
Baseline, 1-month, 6-month
|
Change from baseline femoral cartilage thickness measurement by ultrasound at 6 months
Time Frame: Baseline, 6-month
|
Distal femoral cartilage thickness will be evaluated by the same clinician using the MyLab60 model ultrasonography device and high-resolution 7-12 MHz linear probe available in our clinic.
During the measurement, patients will be positioned in the prone position with their knees in full flexion and ankles in neutral to examine the distal femoral cartilage, and the probe will be placed in the axial position in the suprapatellar area at the outer edge of the patella.
After the distal femoral cartilage is anechogenically imaged between the hyperechogenic bony cortex and suprapatellar fat, the distance between the thin hyperechoic line of the synovial cavity on the stratified face and the hyperechoic sharp line on the bony face of the cartilage will be measured and recorded as the thickness of the cartilage.
Cartilage thickness measurements for each intervention knee will be recorded by recording three measurements from the midpoint: lateral condyle, intercondylar area and medial condyle.
|
Baseline, 6-month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Demirhan Diracoglu, Prof., Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
- Principal Investigator: Ekin I Sen, Asst. Prof., Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
March 22, 2021
Primary Completion (ANTICIPATED)
November 1, 2021
Study Completion (ANTICIPATED)
December 1, 2021
Study Registration Dates
First Submitted
March 17, 2021
First Submitted That Met QC Criteria
March 17, 2021
First Posted (ACTUAL)
March 19, 2021
Study Record Updates
Last Update Posted (ACTUAL)
March 19, 2021
Last Update Submitted That Met QC Criteria
March 17, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Istanbul Universty PRP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Intra-articular T-LAB / PRP KIT injection
-
Dalia Salah SaifUnknownRA - Rheumatoid ArthritisEgypt
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
University of UtahActive, not recruitingPlatelet-Rich Plasma (PRP) | Knee Osteoarthritis (OA)United States
-
Bioheart, Inc.Anupam Hospital; RegennMed Research and Therapeutics DelhiCompleted
-
Istituto Ortopedico RizzoliCompleted
-
South Valley UniversityCompleted
-
St George's, University of LondonWellcome Trust; Rosetrees TrustUnknownRheumatoid Arthritis | Osteoarthritis, Knee | Psoriatic Arthritis | SpondyloarthritisUnited Kingdom
-
University Hospital TuebingenUnknownJuvenile Idiopathic ArthritisGermany
-
Fidia Farmaceutici s.p.a.UnknownKnee OsteoarthritisUnited States
-
LabrhaStatitecCompletedKnee OsteoarthritisFrance